Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Not Confirmed
Not Confirmed
03-07 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Industry Trade Show
Not Confirmed
03-07 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
21 Sep 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/genfit-moves-jump-start-enrollment-slow-going-phase-2-liver-failure-trial
19 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/19/2949420/0/en/GENFIT-Reports-First-Half-Year-2024-Financial-Results-and-Provides-Corporate-Update.html
26 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/26/2919511/0/en/GENFIT-Positive-Opinion-from-EMA-Committee-for-Ipsen-s-Iqirvo-elafibranor-in-Primary-Biliary-Cholangitis.html
09 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/en/news-release/2024/07/09/2910756/0/en/GENFIT-Half-Year-Report-of-Liquidity-Contract-with-Cr%C3%A9dit-Industriel-et-Commercial.html
17 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/17/2900009/0/en/GENFIT-New-EASL-EASD-EASO-Clinical-Practice-Guidelines-for-MASLD-Include-NIS2-as-Key-Tool-for-Detecting-At-Risk-MASH.html
11 Jun 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-genfit-ipsens-liver-disease-drug-2024-06-10/
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?